Friday, November 19, 2021 5:28:10 PM
It’s way way underpriced.don’t even think of selling. Within a yr this will be 5 to 10 bucks. Don’t take the loss as by next yr this time it will be 5 to 10 bucks. Also again Aezs covid pill is a vaccine pill. The other pills are to treat covid. Still im here for pedi approval and other uses for macrilen along with the other catalysts. Now is not the time to dump. Hold. Next yr u will be in the green. God bless all
Recent CSCIF News
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 05/20/2026 08:46:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/20/2026 08:38:12 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 05/12/2026 09:21:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 09:07:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 09:05:51 PM
- COSCIENS Biopharma Inc. Reports Q1 2026 Results • GlobeNewswire Inc. • 05/12/2026 09:05:00 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 05/08/2026 08:45:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2026 08:45:07 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 04/20/2026 12:01:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/20/2026 12:00:12 PM
- COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/17/2026 09:55:15 PM
- COSCIENS Comments on Unusual Market Activity • GlobeNewswire Inc. • 04/07/2026 09:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/07/2026 09:07:44 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 09:05:27 PM
- COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/25/2026 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/19/2026 04:15:19 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/13/2026 09:30:57 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/13/2026 09:30:39 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/13/2026 09:30:14 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/13/2026 09:29:54 PM
